Aim: The efficacy and safety of repeated injections of intravitreal triamcinolone (IVTA) for
diabetic macular oedema is unclear, with results of previous reports conflicting. Methods …

Background/aim: Intravitreal triamcinolone (IVTA) results in transient improvements in
diabetic macular oedema (DMO), necessitating repeated injections. The authors report a …

Objective: To compare the safety and efficacy of different doses of intravitreal triamcinolone
(ivTA) in treating clinically significant diabetic macular oedema (CSMO). Methods: 63 eyes of …

Purpose To evaluate the effect of intravitreal triamcinolone acetonide (IVT) on refractory
diabetic macular edema (DME). Methods In a prospective, placebo-controlled, randomized …

OBJECTIVE: To report 2-year safety and efficacy outcomes from a trial of intravitreal
triamcinolone acetonide (TA) injections (4 mg) in eyes with diabetic macular edema and …

Aim: To evaluate the effect of different doses of intravitreal triamcinolone acetonide on
diffuse diabetic macular oedema. Methods: The prospective, randomised, double masked …

Aim: To report on visual outcome of patients receiving an intravitreal injection of
triamcinolone acetonide for treatment of diffuse diabetic macular oedema. Methods …

Purpose: To compare the efficacy and safety of different doses of intravitreal triamcinolone
(IVTA) in treating eyes with refractory diffuse diabetic macular edema (DME) with cystic …

Purpose To report on the follow-up of patients who received an intravitreal high-dosage
injection of triamcinolone acetonide (IVTA) as treatment of diffuse diabetic macular edema …

PURPOSE: To determine if intravitreal injection of triamcinolone acetonide is safe and
effective in treating diabetic macular edema unresponsive to prior laser photocoagulation …